Lyell Immunopharma (LYEL) Stock Forecast
Analyst ratings, price targets, and earnings estimates.
LYEL Analyst Ratings
Hold
Consensus
Based on 3 analysts in the past 3 months
LYEL Stock 12 Month Forecast
$1.00
▲
(110.44%
Upside)
Highest Price Target
$12.00
(2425.3%)
Average Price Target
$1.00
(110.4%)
Lowest Price Target
$1.00
(110.4%)
Based on 1 analysts in the last year
Recent Price Targets
Recommendation Trends
Analyst Estimates
Revenue Estimates
High
$43.33K
Average
$43.33K
Low
$43.33K
3 analysts
Net Income Estimates
High
$-160.04M
Average
$-217.68M
Low
$-231.78M
3 analysts
EPS Estimates
High
$-0.61
Average
$-0.74
Low
$-0.89
2 analysts
Revenue Estimates
High
$65.00K
Average
$65.00K
Low
$65.00K
3 analysts
Net Income Estimates
High
$-189.35M
Average
$-189.35M
Low
$-189.35M
3 analysts
EPS Estimates
High
$-0.72
Average
$-0.72
Low
$-0.72
2 analysts
Revenue Estimates
High
$54.13K
Average
$54.13K
Low
$54.13K
1 analysts
Net Income Estimates
High
$-104.59M
Average
$-167.01M
Low
$-229.42M
1 analysts
EPS Estimates
High
$-0.40
Average
$-0.64
Low
$-0.88
2 analysts
Latest Price Target Updates
| Date | Analyst | Firm | Price Target | Price When Posted | Upside |
|---|---|---|---|---|---|
| Oct 30, 2024 | Geoff Meacham | Bank of America Securities | $1.00 | $0.95 | 5.5% |
| Nov 14, 2022 | None | Morgan Stanley | $7.00 | $4.53 | 54.5% |
| May 24, 2022 | None | Goldman Sachs | $12.00 | $4.01 | 199.3% |
Related Metrics
Explore detailed financial metrics and analysis for LYEL.